VEGFA and neoplasm: Therefore, the immunostimulatory effect of anti-VEGF therapy could derive from normalizing tumor vasculature, alleviating hypoxia, increasing effector T cell infiltration, decreasing the population of MDSCs and Tregs, and restoring DCs [64,65,66].